Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report

We report a case of a patient with extensive-stage SCLC who developed acquired hemophilia A during maintenance atezolizumab therapy. The patient initially presented with asymptomatic anemia, a prolonged acquired prothrombin time, and factor VIII (FVIII) deficiency. Acquired FVIII autoantibodies were...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, James, Bird, Robert, McLean, Andrew J.W., O’Byrne, Kenneth, Xu, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579496/
https://www.ncbi.nlm.nih.gov/pubmed/36275909
http://dx.doi.org/10.1016/j.jtocrr.2022.100409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579496/
https://www.ncbi.nlm.nih.gov/pubmed/36275909
http://dx.doi.org/10.1016/j.jtocrr.2022.100409

Ejemplares similares